MITCHELL H FRIEDLAENDER
Medical Practice in La Jolla, CA
License number
Michigan 4301029576
Issued Date
Jul 13, 1970
Expiration Date
Jan 31, 2004
Category
Medicine
Type
Medical Doctor
Address
Address
La Jolla, CA 92037
Professional information
Dr. Mitchell H Friedlaender, La Jolla CA - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
10666 N Torrey Pines Rd, La Jolla 92037
(858) 554-9786 (Phone)
(858) 554-9786 (Phone)
Certifications:
Ophthalmology, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
10666 N Torrey Pines Rd, La Jolla 92037
Scripps Green Hospital
10666 North Torrey Pines Rd, La Jolla 92037
Scripps Memorial Hospital La Jolla
9888 Genesee Ave, La Jolla 92037
Sunrise Hospital and Medical Center
3186 South Maryland Pkwy, Las Vegas 89109
Scripps Green Hospital
10666 North Torrey Pines Rd, La Jolla 92037
Scripps Memorial Hospital La Jolla
9888 Genesee Ave, La Jolla 92037
Sunrise Hospital and Medical Center
3186 South Maryland Pkwy, Las Vegas 89109
Education:
Medical School
University Of Michigan Medical School
Graduated: 1969
Barnes Jewish Hospital
Graduated: 1970
Mass Ee Infirm Harvard
Graduated: 1975
Mass Ee Infirm
Graduated: 1976
Uc San Francisco Med Center
Graduated: 1977
University Of Michigan Medical School
Graduated: 1969
Barnes Jewish Hospital
Graduated: 1970
Mass Ee Infirm Harvard
Graduated: 1975
Mass Ee Infirm
Graduated: 1976
Uc San Francisco Med Center
Graduated: 1977
Compositions, Methods, And Kits For Treating Dry Eye
US Patent:
2007025, Nov 8, 2007
Filed:
May 1, 2007
Appl. No.:
11/742924
Inventors:
Mitchell Friedlaender - La Jolla CA, US
Harun Takruri - Newport Beach CA, US
Harun Takruri - Newport Beach CA, US
International Classification:
A61K 38/37, A61K 31/717, A61K 38/39
US Classification:
424427000, 424078370, 424078380, 514055000, 514057000, 514058000, 514054000, 514002000
Abstract:
The present invention is related to a method for treating dry eye, the method comprising administering to a lacrimal punctum a gelatinous or film forming composition. The present invention is also related to ophthalmic compositions, and kits for treating dry eye, the kit comprising (a) the ophthalmic compositions of the present invention; and (b) instructions for using the composition of (a) to treat dry eye.
Ultraviolet Absorbing Ophthalmic Compositions
US Patent:
2008001, Jan 17, 2008
Filed:
Jun 27, 2007
Appl. No.:
11/819492
Inventors:
Mitchell Friedlaender - La Jolla CA, US
Harun Takruri - Newport Beach CA, US
Harun Takruri - Newport Beach CA, US
International Classification:
A61K 31/355, A61K 31/34, A61P 27/02
US Classification:
514458000, 514474000
Abstract:
The present invention is directed to a composition comprising: (a) one or more UV-absorbing agents, wherein all the UV-absorbing agents are in solution; and (b) an excipient; wherein the composition is ophthalmically acceptable, and wherein the composition does not contain an active agent. In some embodiments, the UV-absorbing agent is a vitamin E compound, ascorbic acid, sodium ascorbate, sorbic acid, potassium sorbate, amino acid, or combination thereof. The present invention is also directed to kits comprising the composition described herein.
Methods Of Treating An Ocular Allergy With Low Dose Dexamethasone
US Patent:
2008011, May 22, 2008
Filed:
Nov 1, 2007
Appl. No.:
11/979356
Inventors:
Mitchell H. Friedlaender - La Jolla CA, US
International Classification:
A61K 31/573
US Classification:
514179
Abstract:
The present invention is directed to a method of treating an ocular allergy with a composition comprising a low dose of dexamethasone. In some embodiments, the present invention is directed to a method of treating an ocular allergy, the method comprising administering to an ocular surface of a subject in need thereof a composition comprising about 0.001% to about 0.01% (w/v) dexamethasone.
Method For Treating Blepharitis
US Patent:
2009002, Jan 22, 2009
Filed:
Nov 1, 2007
Appl. No.:
11/979354
Inventors:
Mitchell H. Friedlaender - La Jolla CA, US
International Classification:
A61K 31/573, A61P 29/00, A61K 31/7036
US Classification:
514 40, 514171
Abstract:
The present invention is related to a method for treating blepharitis, the method comprising administering to an ocular area of a subject in need thereof a composition comprising about 0.001% to about 0.01% (w/v) dexamethasone and an antibiotic, wherein the composition is substantially free of lipids, and wherein the composition is ophthalmically acceptable.
Compositions, Methods And Kits For Removing Debris From An Ocular Area
US Patent:
2007016, Jul 19, 2007
Filed:
Dec 12, 2006
Appl. No.:
11/637136
Inventors:
Mitchell Friedlaender - La Jolla CA, US
Harun Takruri - Newport Beach CA, US
Harun Takruri - Newport Beach CA, US
International Classification:
A61K 33/22, A61K 31/4172
US Classification:
424659000, 514400000
Abstract:
The present invention is directed to compositions and kits for removing debris from an ocular area. The present invention is also directed to a method of removing debris from an ocular area.
Methods Of Treating Epiphora
US Patent:
2008014, Jun 19, 2008
Filed:
Nov 1, 2007
Appl. No.:
11/979355
Inventors:
Mitchell H. Friedlaender - La Jolla CA, US
Harun Takruri - Newport Beach CA, US
Harun Takruri - Newport Beach CA, US
International Classification:
A61K 36/61, A61P 27/02
US Classification:
424742
Abstract:
The present invention is related to a method for treating epiphora, the method comprising administering to a nasal area of a subject in need thereof a composition comprising camphor, eucalyptus oil, and menthol, wherein the composition is substantially free of lipids other than the eucalyptus oil.